Trial intelligence / Profile preview

Vitamin D Supplementation for Severe Pneumonia in Under-five Children

NCT02185196Phase 1Completed

Sponsor
icddr,b
Start
Jun 2014
Primary completion
Dec 2017
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in pneumonia comparing Vitamin D3 with Placebo (2 arms). Primary endpoint: Time taken for recovery from severe pneumonia at 12 months. Started Jun 2014; status: completed.

02

Drugs

vitamin d
03

Conditions

pneumonia

Beyond the preview

Go deeper on NCT02185196.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02185196.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call